Characterization and Targeting of Platelet-Derived Growth Factor Receptor alpha (PDGFRA) in Inflammatory Breast Cancer (IBC)()

PURPOSE: Inflammatory breast cancer (IBC) is arguably the deadliest form of breast cancer due to its rapid onset and highly invasive nature. IBC carries 5- and 10-year disease-free survival rates of ~45% and <20%, respectively. Multiple studies demonstrate that in comparison with conventional bre...

Descripción completa

Detalles Bibliográficos
Autores principales: Joglekar-Javadekar, Madhura, Van Laere, Steven, Bourne, Michael, Moalwi, Manal, Finetti, Pascal, Vermeulen, Peter B., Birnbaum, Daniel, Dirix, Luc Y., Ueno, Naoto, Carter, Monique, Rains, Justin, Ramachandran, Abhijit, Bertucci, Francois, van Golen, Kenneth L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2017
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470553/
https://www.ncbi.nlm.nih.gov/pubmed/28609680
http://dx.doi.org/10.1016/j.neo.2017.03.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470553/
https://www.ncbi.nlm.nih.gov/pubmed/28609680
http://dx.doi.org/10.1016/j.neo.2017.03.002

Ejemplares similares